| Date | Title | Description |
| 01.09.2026 | Sun Pharma signs deal with US government to reduce drug prices | Drug major Sun Pharmaceutical Industries has signed a deal with the US government to lower prices of its innovative drugs in the US, in line with the lowest prices paid by other developed nations, under the most favoured nation (MFN) pricin... |
| 05.08.2026 | Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court | - |
| 08.07.2026 | Natco Pharma to raise stake in Adcock Ingram to 49% with ₹1,400 crore investment | - |
| 03.06.2026 | Natco-Lupin get USFDA’s nod for Eribulin Mesylate injection | - |
| 18.05.2026 | Kotak Alts' life sciences fund backs gene therapy firm | Credit: 123RF.com
Kotak Alternate Asset Managers Ltd has invested in Cellogen Therapeutics, a biotechnology firm focussed on cell and gene therapies.
Kotak Alts has invested Rs 20 crore ($2 million) in the biotech firm through its early- to... |
| 20.03.2026 | Here’s everything you need to know about Natco’s latest semaglutide injection launch | - |
| 17.03.2026 | Venture Catalysts exits hygiene startup Pee Safe with 9.6x return after OrbiMed-led $32 million round | Synopsis
Other investors, including We Founder Circle, Alkemi Growth Capital and Alpha Capital, have also exited the company, Venture Catalysts founder Apoorva Ranjan Sharma told ET. Zerodha-backed Rainmatter and Natco Pharma continue to be... |
| 24.02.2026 | Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide | - |
| 12.02.2026 | NATCO Pharma Q3 PAT up | - |
| 03.02.2026 | Natco Pharma gets USFDA nod for cancer generic drug | - |
| 15.01.2026 | Pee Safe Secures $32 Million to Propel Global Hygiene Market Expansion | Pee Safe, a prominent hygiene and wellness brand, recently closed a $32 million Series C funding round. Healthcare-focused private equity firm OrbiMed led this significant investment. The capital injection targets ambitious growth. It will ... |
| 14.01.2026 | Pee Safe raises funding from OrbiMed to scale retail, quick-commerce push | Pee Safe co-founders (from left) Vikas Bagaria and Rithish Kumar
Hygiene and wellness brand Pee Safe has secured capital in a growth funding round from healthcare-focused private equity firm OrbiMed, as it looks to expand its retail and qui... |
| 08.04.2025 | Natco Pharma to price Risdiplam at ₹15,900 | - |
| 12.02.2025 | Natco Pharma’s Q3 net down 37% to ₹132 crore | Natco Pharma’s consolidated net profit declined 37 per cent to ₹132 crore in the third quarter ended December 31, 2024, as against ₹212 crore in the same period last year, on account of a decrease in formulation exports.
The total revenue o... |
| 23.01.2025 | Kotak Alternate Asset hits first close of third life sciences-focused PE fund | Credit: 123RF.com
Kotak Alternate Asset Managers Ltd, the alternative asset management arm of Kotak Mahindra Group, said Thursday it has marked the first close of its third healthcare and life sciences-focused private equity fund.
The firm ... |
| 04.09.2024 | Natco Pharma’s Canadian arm invests $8 million in eGenesis | Natco Pharma’s wholly-owned Canadian subsidiary, Natco Pharma (Canada) Inc., invested $8 million in the US-based biotechnology company, eGenesis, Inc.
“We are excited to get involved with eGenesis, Inc. with respect to their pioneering work... |
| 28.06.2024 | Natco Pharma mulling acquisition in RoW market to strengthen base business | Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business.
“The acquisition space is to strengthen our base business. We have the money to do it and are looking at Rest of the World business... |
| 21.05.2024 | Expect formulations biz to outpace API biz: Biocon Group CEO Peter Bains | - |
| 08.05.2024 | Dr Reddy's Labs slumps 5% as brokerages give 'Reduce' call post Q4 earnings | - |
| 04.05.2024 | Productivity loss due to oral cancer in India in 2022 at $5.6 bn: Study | - |
| 01.05.2024 | Mizoram sees alarming surge in TB deaths, 108 succumb to disease in 2023 | - |
| 23.04.2024 | Natco Pharma gets EIR from USFDA on pharmacovigilance requirements | Natco Pharma has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA).
In November last year, Hyderabad-based Natco informed the successful completion of the United States Food and Drug Adminis... |
| 21.04.2024 | USFDA pulls up Natco Pharma for several violations at Telangana plant | - |
| 09.04.2024 | Maruti Suzuki Expands Manesar Plant's Capacity, Air India Addresses Uniform Issues, Indian Tech Startups See Decline in Layoffs | Maruti Suzuki India has boosted the production capacity of its Manesar facility by 100,000 units per annum, aiming to double its capacity to 4 million vehicles per annum in the next 7-8 years. The expansion includes a new vehicle assembly l... |
| 09.04.2024 | Maruti Suzuki expands Manesar plant's capacity by 100K units per annum | Maruti Suzuki India on Tuesday said it has expanded the production capacity of its Manesar facility by one lakh units per annum.
The auto major has added a vehicle assembly line to the existing Plant-A of the three manufacturing plants func... |
| 09.04.2024 | A-I takes cognizance of fabric issues flagged in new cabin crew uniforms | Air India has received feedback on the new cabin crew uniforms, including about fabric issues, and will soon start their production for all the cabin crew after taking into consideration the inputs, according to people in the know.
In Decem... |
| 09.04.2024 | Merck India appoints Dhananjay Singh as MD of its Life Science unit | Merck, a leading science and technology company, on Tuesday announced the appointment of Dhananjay Singh as the managing director of Merck Life Science in India.
Effective April 1, 2024, Singh has taken over from Sreenath N S, who is retiri... |
| 09.04.2024 | Natco Pharma receives warning letter from USFDA for Telangana plant | Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant.
The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspectin... |
| 28.10.2019 | Merger alert: Newly born ISCA Global doubles down on insect pheromone tech | ISCA Global has been formed through the merger of ISCA Technologies (US), ISCA Tecnologias (Brazil) and ATGC Biotech (India) to bring together 25 years of research and development into insect control products that are less harmful to the en... |
| 11.01.2018 | Natco Pharma gets green nod for Rs 480-cr expansion project | Natco Pharma has received environment clearance (EC) for its Rs 480-crore expansion project in Telangana that would generate 1,500 jobs.
The proposal is to increase the production capacity of 66 Active Pharmaceutical Ingredients (APIs) and ... |
